Showing results (121-130 of 133) with videos related to
Sort By:
Pageof 14
The Journal of Clinical Endocrinology and Metabolism|November 5, 2023
Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease ActivityRaymond S Douglas, Steven Couch, Sara T Wester, et al.Epidemiology and Infection|October 2, 2015
Association between use of proton pump inhibitors and non-typhoidal salmonellosis identified following investigation into an outbreak of Salmonella Mikawasima in the UK, 2013R Freeman, G Dabrera, C Lane, et al.Nucleosides & Nucleotides|August 5, 1999
Gene therapy of cancer: activation of nucleoside prodrugs with E. coli purine nucleoside phosphorylaseJ A Secrist, W B Parker, P W Allan, et al.Viruses|May 27, 2023
Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeutic Vaccine in Guinea PigsSita Awasthi, Motoyasu Onishi, John M Lubinski, et al.Bioorganic & Medicinal Chemistry Letters|December 20, 2011
Novel substituted pyrimidines as HCV replication (replicase) inhibitorsCecil D Kwong, Jeremy L Clark, Anita T Fowler, et al.The Journal of Bone and Joint Surgery. American Volume|January 7, 2021
Low Adherence to Recommended Guidelines for Open Fracture Antibiotic ProphylaxisCarol A Lin, Nathan N O'Hara, Sheila Sprague, et al.Ophthalmology|October 24, 2021
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X StudyRaymond S Douglas, George J Kahaly, Shoaib Ugradar, et al.The New England Journal of Medicine|January 24, 2020
Teprotumumab for the Treatment of Active Thyroid Eye DiseaseRaymond S Douglas, George J Kahaly, Amy Patel, et al.Bioorganic & Medicinal Chemistry Letters|July 21, 2012
Pyridofuran substituted pyrimidine derivatives as HCV replication (replicase) inhibitorsFrank Bennett, Hollis S Kezar, Vinay Girijavallabhan, et al.Bioorganic & Medicinal Chemistry Letters|August 4, 2012
Synthesis and SAR of pyridothiazole substituted pyrimidine derived HCV replication inhibitorsVinay M Girijavallabhan, Carmen Alvarez, Frank Bennett, et al.Pageof 14